
Opinion|Videos|August 27, 2025
Unmet Needs for the Management of Alopecia Areata
Key Takeaways
- Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles.
- Breakdown of immune privilege in hair follicles leads to infiltration by cytotoxic T cells, particularly CD8+ T cells.
Panelists discuss how switching therapies in patients with alopecia areata (AA) is often necessary when initial treatments fail, though it can create a cost burden, and how beyond updated guidelines, there are unmet needs such as improved long-term treatments and better psychological support for patients.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Mostaghimi: What is your approach to switching therapies in patients with AA?
- Discuss how switching therapies can be a cost burden for patients.
- Friedland: Beyond updated guidelines for AA, what are some other unmet needs for the management of this disease?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Promises and Pitfalls of AI in Health Care
2
Texas Sues J&J, Kenvue for Alleged Deception in Acetaminophen Marketing
3
SCRI’s Vivek Subbiah, MD, Highlights Trials on Tumor-Agnostic Cancer Therapies During ESMO
4
With New OUD Diagnoses on the Rise, More Comprehensive Screenings Needed
5














































